SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors weigh the potential for a transformative buyout ahead of a long-awaited trial event, while the community remains sharply divided between bulls anticipating a massive premium and bears expressing skepticism over trial timelines and asset efficacy.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing a massive parabolic rally fueled by severe NAND flash and SSD supply constraints, with community sentiment deeply polarized between retail investors chasing the momentum and bears warning of an unsustainable AI-driven bubble. Traders are closely monitoring the impact of Apple's recent memory price hikes and upcoming Micron earnings, as the community debates whether the stock represents a structural growth story or a historic speculative mania.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust is trending as traders closely monitor escalating geopolitical tensions in the Strait of Hormuz and the status of US-Iran negotiations, which remain a primary driver of market sentiment. The community is actively debating the sustainability of the current AI-led market rally, with many investors weighing the risks of high capital expenditures against potential economic instability and rising interest rates.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant community attention as investors position for imminent long-term efficacy results from the VELA Phase 3 program, which many view as a critical rerating catalyst. With institutional interest rising and active discussions focused on the potential for superior clinical data compared to current market leaders, participants are closely monitoring the upcoming investor conference for possible M&A discussions or pipeline updates.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing significant momentum as investors digest unconfirmed reports of a domestic chip manufacturing partnership with Apple, further fueled by government-backed foundry initiatives. The stock remains a focal point for community debate, with traders weighing a potential multi-year turnaround narrative against concerns that current price levels may already be extended following a period of rapid appreciation.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is seeing strong investor engagement driven by its structural positioning in the AI data center market and excitement surrounding upcoming product catalysts. The community is actively discussing the stock's role in the broader semiconductor sector rotation, focusing on its ability to capture long-term demand for compute power amidst shifting macroeconomic conditions.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently trending as the community scrutinizes the company's shift toward high-volume commercial scaling and its strategic expansion into smart glasses, drones, and wearable markets. Investors are actively debating the viability of the company's manufacturing throughput and the recent shift in battery qualification timelines, while monitoring the broader implications of its expanding supply chain partnerships across Asia.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing high volatility as investors balance excitement over its critical role in the optical networking infrastructure for AI data centers with concerns regarding production execution and repeated insider selling. Community discussions are heavily split between those targeting a breakout driven by AI-driven bandwidth demand and skeptics pointing to high valuations and dilution risks.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The semiconductor sector, led by the VanEck Semiconductor ETF (SMH), continues to command intense investor focus as it hits all-time highs, fueled by relentless AI infrastructure buildout and massive inflows. However, the community is sharply divided, with bulls pointing to intact technical momentum and secular growth, while bears warn of extreme crowding, speculative exhaustion, and the potential for a painful late-cycle reversal.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is gaining traction as traders debate its long-term utility in the IoT and data sovereignty space, while the community remains sharply divided between those accumulating at current levels and others dismissing the project as a speculative pump-and-dump cycle. Investor discourse is currently dominated by conflicting views on the project's ecosystem expansion versus concerns over historical price performance and tokenomics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer

CONMED Corporation (NYSE: CNMD) today announced the appointment of John E. Gallagher as Chief Financial Officer (CFO), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. We are pleased to welcome a talented and...

Here's Why You Should Retain CONMED Stock in Your Portfolio Now

CNMD is sharpening its focus on AirSeal, Buffalo Filter and BioBrace, betting on higher-growth platforms to drive margin gains and long-term growth.

Why Is Conmed (CNMD) Down 3.1% Since Last Earnings Report?

Conmed (CNMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?

CAH's fast-growing Other Growth Businesses posted 34% revenue growth and 52% profit gains, raising their role in long-term earnings.

CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors

CONMED Corporation (NYSE: CNMD) today announced the appointment of Celine Martin and Jeff Mirviss to its Board of Directors (Board), effective July 1, 2026. Ms. Martin will serve as a member of the Audit Committee and the Strategy Committee, and Mr. Mirviss will serve as a member of the...

Is the Options Market Predicting a Spike in CONMED Stock?

Investors need to pay close attention to CNMD stock based on the movements in the options market lately. 

CONMED (NYSE:CNMD) Price Target Lowered to $39.00 at Wells Fargo & Company

Wells Fargo & Company reduced their target price on CONMED from $42.00 to $39.00 and set an "equal weight" rating on the stock in a research note on Friday...

CONMED (NYSE:CNMD) Price Target Lowered to $40.00 at JPMorgan Chase & Co.

JPMorgan Chase & Co. lowered their price target on shares of CONMED from $43.00 to $40.00 and set a "neutral" rating on the stock in a report on Thursday...

CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up

CNMD tops Q1 estimates despite sales dip, lifts 2026 organic growth outlook as strategic shift sharpens focus on higher-growth segments.

CONMED Q1 Earnings Call Highlights

CONMED (NYSE:CNMD) executives told investors the company is sharpening its focus on higher-growth, higher-margin platforms after reaching agreements to divest its gastroenterology (GI) product lines...

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Conmed Corp.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

CNMDConmed Corp.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CNMD News